Navigation Links
Cypin Production Announces Launch of U.S./China BioPharma Conference:
Date:11/3/2010

PHILADELPHIA, Nov. 2, 2010 /PRNewswire/ -- Cypin Production, a leader in bringing together experts in biopharmaceuticals in the United States and China, is pleased to announce the already-high interest being garnered for its upcoming conference:  "U.S.-CHINA PHARMA: Innovative Strategies and Partnership Models for R&D Success".

The conference, which is scheduled for May 23-24, 2011 at the Hub Cira Centre in Philadelphia, is being chaired by Mikael Dolsten, M.D., Ph.D., President of Worldwide Research & Development (WRD) at Pfizer. A physician with more than 20 years experience in the pharmaceutical industry, Dr. Dolsten oversees thousands of world-class scientists and researchers and understands how important it is for today's U.S. bio-pharma leaders to have strong liaisons with their colleagues in China.

The conference is already off to a strong start, having garnered a renowned speaker faculty. Among the companies whose experts on best practices will be featured: Pfizer Worldwide Research & Development, Merck & Co., Novartis Vaccines & Diagnostics, Abbott Laboratories, Genzyme Transplant and Oncology, LIMR Chemical Genomics Center, the University City Science Center, Crown Bioscience, Bay City Capital, and Safeguard Scientifics, to name just a few.

Among the topics scheduled for this conference are:

  • Comparing China, China's key Asian competitors, and the United States in terms of strengths and weaknesses in pharmaceutical R&D (discovery, preclinical, chemical & formulation, and clinical)
  • Exploring emerging business models and key drivers for U.S.-China Pharma R&D partnerships
  • Important cross-cultural aspects of conducting business activities in China
  • Identifying R&D strategies to cost-effectively expand product portfolios
  • Discussing new strategies to feed R&D pipeline through academic/industry partnerships
  • Examining
    '/>"/>

SOURCE Cypin Production
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Replidynes Investigational Antibacterial Agent REP3123 Prevents Toxin Production in Clostridium difficile
2. New Study: Pine Bark Extract Boosts Nitric Oxide (NO) Production
3. SAIC Awarded Malaria Vaccine Production Support Contract Extension by the National Institute of Allergy and Infectious Diseases
4. Increasing Dairy Milk Production with Electrolyzed Drinking Water
5. Pew Commission Says Industrial Scale Farm Animal Production Poses Unacceptable Risks to Public Health, Environment
6. Wacker Validates Scalability of Anticalin(R) Production With E.coli Secretion Technology and Will Produce Pieris First Clinical Candidate PRS-050
7. Artelis and Selexis Report Record Antibody Production Levels in CHO Cells of Over 31 Grams Per Liter
8. Southern Research Institute Wins $14.7 Million NIH Award to Participate in Molecular Libraries Probe Production Center Network
9. DSM and LibraGen Sign Agreement to Co-Develop Transaminases for Production of Chiral Amines
10. FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder
11. Study Demonstrates that AHCC(R) Enhances Immune System by Increasing the Production of Key Dendritic Cells
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)...  In anticipation of the upcoming MEDevice San Diego ... the first time. Industry Overview: Medtech & Life Sciences ... snapshot of San Diego,s critical involvement ... latest employment statistics to current venture capital investment trends, the ... such a vital part of the global medical device ...
(Date:8/28/2014)... LONDON , Aug. 28, 2014  A candidate ... The Gambia and Mali ... safety trials of potential vaccines aimed at preventing the disease that ... West Africa . Human trials of ... Health (NIH) and GlaxoSmithKline, are to be accelerated with funding from ...
(Date:8/28/2014)... 2014 According to a new ... (RFID) Market (Tags, Readers, Middleware, Printers and Cabinets) - ... 2014 - 2020" the global radiofrequency identification (RFID) market ... is expected to grow at a CAGR of 13.9% ... of USD 5.3 billion in 2020. Browse ...
Breaking Medicine Technology:New Infographic Published - Overview of Medtech & Life Sciences Industry in San Diego 2Ebola vaccine trials fast-tracked by international consortium 2Ebola vaccine trials fast-tracked by international consortium 3Ebola vaccine trials fast-tracked by international consortium 4Ebola vaccine trials fast-tracked by international consortium 5Ebola vaccine trials fast-tracked by international consortium 6Ebola vaccine trials fast-tracked by international consortium 7Radiofrequency Identification (RFID) Market in Healthcare is Expected to Reach USD 5.3 Billion Globally by 2020: Transparency Market Research 2Radiofrequency Identification (RFID) Market in Healthcare is Expected to Reach USD 5.3 Billion Globally by 2020: Transparency Market Research 3Radiofrequency Identification (RFID) Market in Healthcare is Expected to Reach USD 5.3 Billion Globally by 2020: Transparency Market Research 4Radiofrequency Identification (RFID) Market in Healthcare is Expected to Reach USD 5.3 Billion Globally by 2020: Transparency Market Research 5
... Md., Sept. 15 Pre-mixed insulin,analogues, a modified ... than long-acting analogues for controlling high blood sugar,levels ... according to a report,funded by the Agency for ... of Health and Human Services., Conventional pre-mixed ...
... Results inconclusive, as primary outcome measure not statistically ... by improvement in placebo group, ... -- Overall safety and tolerability profile comparable to placebo, ... -- Next steps include further analysis of full dataset ...
Cached Medicine Technology:Modified Insulin Most Effective For Controlling Post-Meal Blood Sugar Levels 2Modified Insulin Most Effective For Controlling Post-Meal Blood Sugar Levels 3AstraZeneca and Targacept Announce Top-Line Results from Phase IIb Study of AZD3480 in Alzheimer's Disease 2AstraZeneca and Targacept Announce Top-Line Results from Phase IIb Study of AZD3480 in Alzheimer's Disease 3AstraZeneca and Targacept Announce Top-Line Results from Phase IIb Study of AZD3480 in Alzheimer's Disease 4
(Date:8/29/2014)... New York (PRWEB) August 29, 2014 ... of Micro-Needling services in their Latham aesthetic office. ... technology, is one of the first surgeons in the ... . The innovative technique is faster and safer ... , Micro-Needling is a noninvasive procedure , ...
(Date:8/29/2014)... Aug. 29, 2014 (HealthDay News) -- Researchers have discovered ... their brains. Dyslexia -- the most commonly diagnosed ... with reading and writing. Previous research showed that ... most of those studies focused only on a small ... functional MRI to analyze how multiple brain regions use ...
(Date:8/29/2014)... August 29, 2014 Parker Waichman LLP, ... to protecting the rights of victims who have been ... (DEA) has announced new regulations for all hydrocodone combination ... (RAPS) report dated August 21, 2014, the DEA ... drugs under federal law. , The long-awaited announcement ...
(Date:8/29/2014)... Hastings and Hastings, a Phoenix personal injury ... many years is pleased to report having saved a ... convenient locations throughout the Valley, Hastings and Hastings offers ... attorney. In addition, experienced personal injury lawyers can arrange ... dedication and service is indicative of a law firm ...
(Date:8/29/2014)... August 29, 2014 Many Americans are ... keep diabetes type 2 at bay, patients should consider ... make the necessary lifestyle changes. While some diabetes risk ... history, advanced age, or belonging to certain ethnic groups, ... – their weight. Carrying extra pounds, especially in the ...
Breaking Medicine News(10 mins):Health News:Williams Revjuva Center Brings Micro-Needling to Latham 2Health News:Scientists Find Differences in Brains of Those With Dyslexia 2Health News:The Drug Enforcement Agency (DEA) Just Announced Plans to Regulate All Hydrocodone Combination Drugs as Schedule II Drugs, Parker Waichman LLP Comments 2Health News:The Drug Enforcement Agency (DEA) Just Announced Plans to Regulate All Hydrocodone Combination Drugs as Schedule II Drugs, Parker Waichman LLP Comments 3Health News:Hastings and Hastings Is Pleased To Report Having Saved A Client $20,900 On A Settlement Of $190,000 2Health News:Hastings and Hastings Is Pleased To Report Having Saved A Client $20,900 On A Settlement Of $190,000 3Health News:Diet Doc Announces Specialized Diet Plans that Help Patients Prevent Diabetes by Stabilizing Blood Sugar Levels and Losing Excess Fat 2Health News:Diet Doc Announces Specialized Diet Plans that Help Patients Prevent Diabetes by Stabilizing Blood Sugar Levels and Losing Excess Fat 3
... Reinberg HealthDay Reporter , TUESDAY, Oct. 5 ... scans for injury-related emergency room visits in the United ... "There has been a dramatic increase in the likelihood ... to emergency departments for injury-related conditions without a corresponding ...
... DATE: Dana-Farber/Children,s Hospital Cancer Care is hosting the 42nd Congress ... pediatric oncology meeting in the world, SIOP is returning to ... Dates:, Thursday, Oct. 21, through Sunday, Oct. 24, ... p.m., Thursday through Saturday, and 8 a.m. to 3 p.m. ...
... Serena Gordon HealthDay Reporter , TUESDAY, Oct. 5 ... they not only protect themselves throughout their pregnancy but may ... few months of life. A study published online ... Medicine found that when women were vaccinated in the ...
... GRAND RAPIDS, MICH., Oct. 5, 2010 Only about ... and vegetable intake recommendations, which means they are ... health benefits (1). Along with vitamins, minerals and fiber, ... carotenoids, which research suggests help support women,s health including ...
... , TUESDAY, Oct. 5 (HealthDay News) -- Sophisticated brain ... patients with mild cognitive impairment are likely to progress ... combination of specialized MRI scans and an artificial intelligence ... were able to predict which patients had mild cognitive ...
... the microscope in a major new study, led by an ... its potential advantages and disadvantages. The study, which is ... examine the motives people have for travelling across national boundaries ... hip or joint replacement, cosmetic surgery and fertility treatment. ...
Cached Medicine News:Health News:MRI, CT Scans for ER Patients Triple Over Decade 2Health News:MRI, CT Scans for ER Patients Triple Over Decade 3Health News:Boston, Oct. 21-24: Largest international pediatric oncology conference 2Health News:Mom's Flu Shot May Protect Baby After Birth 2Health News:Mom's Flu Shot May Protect Baby After Birth 3Health News:Shortfalls in carotenoid intake may impact women's health 2Health News:Shortfalls in carotenoid intake may impact women's health 3Health News:Shortfalls in carotenoid intake may impact women's health 4Health News:Computer-Aided MRI Might Help Predict Alzheimer's 2Health News:Computer-Aided MRI Might Help Predict Alzheimer's 3Health News:Traveling for treatment: The case for and against 2
The Perfecta IMC Stems, manufactured from forged cobalt- chrome, are specifically designed for cemented femoral stem arthroplasty....
The APR Hip System offers a complete line of stems to precisely match patients' anatomic needs and address surgeon preferences....
Simple straight stem design for the low-demand patient....
Dual offset femoral stems, hip stems that provide unique and competitive features....
Medicine Products: